University Of California, Irvine (Uci) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Location
Irvine, California, USA
Type
Public Research University
Website
https://www.uci.edu
The University of California, Irvine (UCI) is a public research university located in Irvine, California. Founded in 1965, UCI has rapidly grown into one of the nation's top research universities, with particularly strong programs in neuroscience, biological sciences, and medicine. The campus spans 1,500 acres in Orange County and houses over 36,000 students across numerous graduate and professional programs.
UCI houses several major research centers focused on neurodegenerative diseases:
- UCI Institute for Memory Impairments and Neurological Disorders (MIND): Leading AD research center
- Center for Neural Circuit Mapping: Brain connectivity and neurodegeneration
- Institute for Immunology: Neuroinflammation research
- Sue & Bill Gross Stem Cell Research Center: Stem cell therapies for neurodegeneration
- Center for Autism Research and Treatment: Neurodevelopmental and neurodegenerative intersections
| Area |
Description |
| Alzheimer's Disease |
Early detection, biomarkers, therapeutic targets |
| Parkinson's Disease |
Dopaminergic neuron dysfunction, LRRK2 research |
| Neuroinflammation |
Microglia, TREM2, innate immune responses |
| Stem Cell Therapy |
iPSC-derived neurons for disease modeling |
| Epilepsy |
Seizure mechanisms in neurodegeneration |
- Dr. Joshua Grill: Alzheimer's disease clinical trials, UCI MIND director
- Dr. Frank LaFerla: Alzheimer's disease researcher, Nobel laureate
- Dr. Leslie Thompson: Huntington's disease, stem cell research
- Dr. Athena Efstratiadis: Neuroscience, neural development
- Dr. Ira van Duyne: Protein misfolding, prion diseases
¶ Recent Discoveries and Research Advances
UCI researchers have made significant contributions to neurodegenerative disease research:
- Tau Propagation: Dr. LaFerla's lab demonstrated mechanisms of tau spread in Alzheimer's disease models
- iPSC Models: Generated patient-derived stem cells to model sporadic Alzheimer's and Parkinson's
- TREM2 Biology: Contributed to understanding TREM2 variants and Alzheimer's risk
- Alpha-Synuclein: Research on α-synuclein aggregation and dopaminergic vulnerability
UCI offers comprehensive training in neuroscience and neurodegeneration:
- Neuroscience Graduate Program: PhD training in cellular, molecular, and systems neuroscience
- Biological Sciences Graduate Program: Training in molecular neuroscience and disease mechanisms
- Medical Scientist Training Program (MD/PhD): Combined training for physician-scientists
- Postdoctoral Training in Neuroscience: Advanced training for recent PhD graduates
- Clinical Fellowships: Movement disorders and behavioral neurology fellowships
- Alzheimer's Disease
- Parkinson's Disease
- Huntington's Disease
- ALS
- Multiple Sclerosis
- Epilepsy
- Autism Spectrum Disorders
UCI maintains active research collaborations globally:
- UK Dementia Research Institute: Joint projects on protein aggregation
- German Center for Neurodegenerative Diseases (DZNE): Biomarker studies
- Japanese Society for the Promotion of Science: Annual symposium on neuroscience
- Chinese Academy of Sciences: Joint stem cell research initiatives
The study of University Of California, Irvine (Uci) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- UCI MIND Institute Annual Report 2025. University of California, Irvine.
- LaFerla FM. "Pathogenesis of Alzheimer's Disease." UCI School of Medicine.
- Grill JD, et al. "Clinical Trials in Early Alzheimer's Disease." UCI MIND.
- Thompson L, et al. "Stem Cell Approaches to Huntington's Disease." Stem Cell Reports.
- "UCI Neuroscience Research Strategic Plan 2025-2030."
- Plotkin, S. et al. (2024). "TREM2 and Neuroinflammation." Nature Neuroscience.